Dose-Dependent Effect of Early Antiplatelet Therapy in Acute Ischemic Stroke
NCT01273935 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2011-01-11
Summary
The aim of this study is to evaluate the low-response prevalence of early antiplatelet therapy and to test the influence of different aspirin dosages in patients with acute ischemic strokes (AIS).
Conditions
- Test the Efficacy of Antiplatelet Regimes in Acute Stroke
Sponsors & Collaborators
-
Ruhr University of Bochum
lead OTHER
Principal Investigators
-
Saskia H Meves, MD · Department of Neurology, St. Josef - Hospital, Bochum, Germany
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-01-31
- Completion
- 2010-12-31
Countries
- Germany
Study Locations
More Related Trials
-
Pilot Study of Continuing Aspirin Versus Switching to Clopidogrel After Stroke or Transient Ischemic Attack
NCT00363753 ·Status: WITHDRAWN ·Phase: PHASE1
-
Double Randomized and Placebo Controlled Trail of Sanchitongshu Combined Antiplatelet Drug to Prevent Ischemic Stroke
NCT04142151 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of High and Low-Dose Simvastatin on Vascular Oxidative Stress and Neurological Outcome in Patients With AIS
NCT03402204 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of DLBS1033 in Patients With Acute Ischemic Stroke
NCT01790997 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study in Acute Ischaemic Stroke
NCT00144014 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase Ib/II in Patients With Acute Ischemic Stroke
NCT02963376 ·Status: COMPLETED ·Phase: PHASE1
-
Early Antiplatelet for Minor Stroke Following Thrombolysis (EAST)
NCT05193071 ·Status: COMPLETED ·Phase: PHASE4
-
Prescription and Persistence of Antithrombotic Agents in Acute Ischemic Stroke or Transient Ischemic Attack Patients With MCA(Middle Cerebral Artery) Disease
NCT02953405 ·Status: UNKNOWN
-
Novel Oral Anticoagulants in Stroke Patients
NCT02353585 ·Status: COMPLETED
-
Argatroban Combined With Antiplatelet Versus Antiplatelet for Acute Ischemic Stroke
NCT03552354 ·Status: COMPLETED ·Phase: PHASE4
-
Statins Role in Acute Ischemic Stroke
NCT06371495 ·Status: NOT_YET_RECRUITING
-
Antiplatelet Therapy for AIS Patients With Thrombocytopenia
NCT06053021 ·Status: RECRUITING ·Phase: NA
-
Intensive Drug Therapy for Ischemic Stroke
NCT05620615 ·Status: UNKNOWN
-
Antiplatelet Therapy for Silent Brain Infarction
NCT03318744 ·Status: UNKNOWN ·Phase: NA
-
Alteplase in Elderly Acute Ischemic Stroke (AIS) Patients During Hospitalization
NCT05395351 ·Status: COMPLETED
-
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
NCT01208233 ·Status: TERMINATED ·Phase: PHASE2
-
Combined Treatment With Alteplase (Rt-PA) and Cerebrolysin® in Acute Ischemic Hemispheric Stroke
NCT00840671 ·Status: COMPLETED ·Phase: PHASE3
-
Dose Finding Study of MCI-186 in Acute Ischemic Stroke
NCT03346538 ·Status: TERMINATED ·Phase: PHASE2
-
Safety and Efficacy of Alteplase When Administered in Chinese Patients With Acute Ischemic Hemispheric Stroke Where Thrombolysis is Initiated Between 3 and 4.5 Hours After Stroke Onset
NCT02930837 ·Status: COMPLETED ·Phase: PHASE3
-
Rt-PA in the Treatment of Acute Ischemic Stroke
NCT00153036 ·Status: COMPLETED ·Phase: PHASE3
-
Thrombolysis Outcome in Ischemic Stroke
NCT04309357 ·Status: COMPLETED
-
A Study to Evaluate the Safety and Potential Efficacy of LT3001 Drug Product in Subjects With AIS
NCT04091945 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy Study of Combined Treatment With Uric Acid and rtPA in Acute Ischemic Stroke
NCT00860366 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke With Atrial Fibrillation 2
NCT07139314 ·Status: RECRUITING ·Phase: NA
-
Early Antiplatelet Therapy After Hemorrhagic Infarction in Acute Ischemic Stroke Treated With Intravenous Thrombolysis (HITs)
NCT04624295 ·Status: RECRUITING ·Phase: PHASE4